AMW expands management team for strategic expansion course

  • Sebastian Herzog as Chief Operating Officer responsible for Production, Quality, Supply Chain, Engineering, Operational Excellence and Logistics
  • Finance and IT under the new management of Matthias Dittmer

Warngau, November 28, 2023

AMW GmbH, a pharmaceutical company specializing in innovative drug delivery systems, today announced the expansion of its management team to implement its strategic growth strategy. After taking over the role of Chief Executive Officer (CEO) from Philipp Karbach in June of this year, Sebastian Herzog is strengthening the management team with his many years of industry expertise in the role of Chief Operating Officer (COO). Financial expert Matthias Dittmer takes over the Finance and IT division as Vice President.

Sebastian Herzog has headed the Operations division as COO since April 2023 and is driving the strategic expansion of the AMW site in Warngau in his new position. His area of responsibility includes the Production, Quality, Supply Chain, Engineering, Operational Excellence and Logistics departments. As an experienced executive with global expertise in the chemical-pharmaceutical and consumer health industries, he has shaped transformation processes in various companies, including the Ontex Group, Gruenenthal GmbH and Bayer AG. Throughout his career, he gained significant experience in the areas of lean manufacturing, supply chain, project engineering and quality. Mr. Herzog holds a Master of Business Administration in Production Management from Koblenz University of Applied Sciences as well as education and training degrees in engineering and chemical process engineering.

Matthias Dittmer, Vice President Finance and IT, assumed responsibility for this area in October 2023. In his previous positions at Eurofins Scientific, TE Connectivity and Sirona Dental Systems, among others, he gained extensive experience in controlling and financial reporting, as well as the implementation of ERP systems in complex, highly regulated industries with international group structures. Mr. Dittmer holds a degree in economics from Ludwig-Maximilians-University in Munich, Germany.

“AMW has set itself ambitious goals. In addition to the global availability of our approved products Goserelin and Leuprorelin, these include in particular the expansion of production capacities while at the same time increasing customer satisfaction. We are therefore delighted to have Sebastian Herzog on board as a highly experienced manager. We are convinced that the establishment of a benchmark factory in line with international standards under his leadership will make a significant contribution to the value development of our company in the coming years,” said Philipp Karbach, CEO of AMW. “I am also delighted that we have been able to recruit Matthias Dittmer as Vice President Finance and IT for our company at this crucial time. With his extensive experience, particularly in the area of controlling, he will support the strategic course of our management team and implement process optimizations. With these latest personnel additions, we are well on the way to achieving our goal of providing patients and our partners with improved medicines to increase treatment adherence and enable cost-effective therapies.”


About AMW:

AMW GmbH is a specialty pharmaceutical company focused on biodegradable sustained-release drug delivery systems, providing patients and partners access to value-added medicines and cost-effective therapies. Based on its technology platform, the Company builds on a growing own and partnered development pipeline. AMW has two approved products, goserelin and leuprorelin implants, which are distributed worldwide through both local and global pharma partners. In Germany, leuprorelin is marketed as Leugon® by AMW’s wholly owned subsidiary Endomedica GmbH. To support pharma and biotech partners in the development and manufacturing of their products and life-cycle solutions, AMW uses its leading-edge formulation development expertise.

AMW is based in Warngau near Munich, Germany.

For further information please contact:


Eva Hoffmann

Phone: +49 8024 470999-0